GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Clinical trials for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS explained in plain language.
Never miss a new study
Get alerted when new GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS trials appear
Sign up with your email to follow new studies for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug tested to fix irregular periods in teens
Disease control ENROLLING_BY_INVITATIONThis study is looking at whether adding a GLP-1 drug (dulaglutide) to standard insulin therapy can help regulate menstrual cycles in teenage girls with Type 1 diabetes. It will involve 50 girls aged 12-18 who have poorly controlled diabetes and irregular periods. The goal is to s…
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Phase: PHASE1, PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Popular ozempic-like drugs may pose hidden risk during surgery, study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how diabetes and weight-loss medications called GLP-1 receptor agonists (like Ozempic or Wegovy) slow stomach emptying. Researchers want to determine if patients taking these drugs need to fast for a longer period before elective surgery to reduce th…
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Sponsor: Wael Saasouh, MD • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC